Principal ML Scientist – Predictive Toxicology

Apheris

Vérifier les pays autorisésPublié le 03 août 2026Annonce confirmée active le 16 nov. 2026
Temps pleinHealthcare

Briefing du poste

Lu dans l’annonce et comparé à notre index d’offres

Candidature depuis
Non précisé
À vérifier auprès de l’employeur
Mode de travail
Entièrement à distance
Texte complet de l’annonce vérifié
Salaire
Non précisé
Niveau
Lead

Le poste en 30 secondes

Traduit de l’anglais

Apheris recherche une personne expérimentée pour piloter son développement en toxicologie prédictive et en biologie quantitative. Ce poste associe modélisation pratique, définition de la stratégie scientifique et collaboration étroite avec les clients et partenaires en découverte de médicaments.

Points clés de l’annonce

  • Définir la stratégie scientifique pour les méthodes de toxicologie et de biologie quantitative.
  • Développer des modèles prédictifs et les intégrer aux programmes de découverte de médicaments.
  • Mener les échanges scientifiques et travailler en autonomie avec les clients et partenaires.
  • Doctorat ou expérience équivalente et au moins six ans d’application du ML aux sciences de la vie ou à la découverte de
  • machine learning
  • deep learning
  • federated learning
  • graph neural networks
  • transformer-based models
  • RNA-seq
  • multi-omics
  • cell painting

Bon à savoir

Dans notre index depuis le
30 août 2026
Employeur
7 autres postes ouverts chez Apheris dans notre index. Dont 5 entièrement à distance. Voir les emplois remote chez Apheris

Généré automatiquement par nomado24 à partir de l’annonce et de notre index. Il ne s’agit pas d’une déclaration de l’employeur. Seule l’annonce d’origine fait foi.

Description du poste

About Apheris

At Apheris, we power federated data networks in life sciences to enable the development of machine learning models that outperform what any single organisation can build alone. Biopharma can only synthesise and test a finite number of compounds across assays, structural biology workflows, and complex ADME and toxicity endpoints, limiting the performance of models trained on in-house data.

The Apheris product addresses this by hosting networks where biopharma organisations collaboratively train higher-quality models on their combined proprietary datasets without sharing the underlying data. Our federated computing infrastructure, with built-in governance and privacy controls, ensures that data IP and ownership always remain with the data custodians

About the role

  • We're looking for an experienced (principal) scientist to own and grow our expansion into small molecule predictive toxicology and quantitative biology.
  • This is a hands-on scientific leadership role: you'll set scientific vision, lead customer and consortium conversations, and integrate real scientific workflows into our platform, turning ambitious scientific goals into models that get used in real drug programmes.
  • You'll operate with a high degree of autonomy, owning this agenda end-to-end and acting as a scientific counterpart to customers and partners.

What you will do

  • Own our expansion into predictive toxicology and quantitative biology. Take the lead as we grow beyond ADME into the science shaping safe, efficacious therapeutics (for example, multi-omics technologies, image-based screening, high-throughput screening and compound-triage cascades).
  • Set the scientific strategy. Define how in silico toxicology and quantitative biology workflows come together across our networks, and which endpoints, assays and modelling approaches deliver value in real drug-discovery decisions.
  • Decide how best to use relevant data. Bring your understanding of how these techniques and data are generated and embedded in pharmaceutical R&D, and turn it into a clear view of how to extract the most scientific and commercial value from them.
  • Span multiple scientific surfaces. Bring depth across the readouts and endpoints that matter for safety and efficacy, from structure-based off-target liability through to pathway-level, mechanistic interpretation and in vivo pharmacokinetics. Integrate these workflows into our platform so customers can run them at scale.
  • Build models that matter . Apply federated learning across partner data to deliver models with performance and applicability no single organisation could achieve—and work closely with industrial partners to embed them in real drug-discovery pipelines.
  • Lead the scientific conversation  with customers and partners, owning scope, evaluation, delivery and adoption in live drug programmes, while shaping the roadmap around genuine scientific and commercial need.

What we expect from you

  • Strong deep learning foundations for molecular AI, for example experience with the architectures commonly used for molecular property modelling (e.g. graph neural networks, message-passing and transformer-based models).
  • A profile that clearly demonstrates you understand the concerns that drive toxicity assessment in drug discovery — whatever the specific toxicity endpoints you've worked on (for example DILI, cytotoxicity, or micronucleus/genotoxicity imaging readouts).
  • Tangible experience building predictive models and driving the adoption of toxicity models in real drug-discovery programmes or industrial R&D pipelines, working closely with teams to get models into pipelines.
  • Working knowledge of how RNA-seq, toxicity screens and image-based screens are used in pharma as part of routine HTS and compound triage.
  • Scientific leadership excellence: able to set vision, own a scientific agenda, and lead technical and customer conversations independently.
  • Comfortable staying hands-on in the modelling while setting scientific direction and mentoring others — this is a scientific leadership role first, with the opportunity to build and lead a team over time.
  • PhD or equivalent experience in a relevant field (computational biology, cheminformatics, toxicology, ML, or similar), plus 6+ years applying ML to drug discovery/life science problems.

Nice to have

  • Experience with federated learning, privacy-preserving ML, or other multi-party training environments.
  • Evidence of prospectively validating predictive toxicity models and using them to influence compound design, prioritisation or progression decisions in live drug-discovery programmes.
  • Production-grade model delivery in regulated, enterprise, pharmaceutical, or biotech settings, and/or a publication record in relevant computational biology, toxicology, or ML venues.
  • Multi-omics and high-content imaging experience (e.g. cell painting).
  • Familiarity with public toxicology and bioactivity data resources (e.g. Tox21, …
Drug Discovery ScienceResearch and Sciencepermanent

Cette offre provient d'une source externe. Les candidatures sont gérées sur le site de la source.

Nouveaux emplois à distance comme « ML Scientist » par e-mail

Gratuit, et seulement quand une offre correspond.

Confirmez par e-mail. Désinscription à tout moment. politique de confidentialité.

Toutes les offres : Emplois data en remote

Catégories d’emplois correspondantes

Pas la bonne offre ?

Résultats pour votre profil : deux sont gratuits, avec Nomado24 Pro vous en voyez jusqu’à 24. Voir Pro